HM2016-25 A Phase 2 Study of the Safety, Tolerability, a

  • Afrin, Lawrence B (PI)

Project: Research project

Project Details

Description

HM2016-25 A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
StatusFinished
Effective start/end date9/28/166/12/18

Funding

  • Incyte Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.